Pagnotti G, Chan M, Adler B, Shroyer K, Rubin J, Bain S
Bone. 2016; 90:69-79.
PMID: 27262776
PMC: 4970889.
DOI: 10.1016/j.bone.2016.05.014.
Zemble R, Takach P, Levinson A
J Clin Immunol. 2011; 31(5):737-43.
PMID: 21643891
DOI: 10.1007/s10875-011-9548-0.
Kyrtsonis M, Mouzaki A, Maniatis A
Med Oncol. 1999; 16(2):73-7.
PMID: 10456654
DOI: 10.1007/BF02785839.
Schebesch C, Kodelja V, Muller C, Hakij N, Bisson S, Orfanos C
Immunology. 1998; 92(4):478-86.
PMID: 9497489
PMC: 1364153.
DOI: 10.1046/j.1365-2567.1997.00371.x.
Eisenstein T, Bushnell B, Meissler Jr J, Dalal N, Schafer R, HAVAS H
Med Oncol. 1995; 12(2):103-8.
PMID: 8535659
DOI: 10.1007/BF01676710.
PWM-induced generation of immunoglobulin-secreting cells in patients with multiple myeloma.
Sieber G, Enders B, Ruhl H
Klin Wochenschr. 1981; 59(19):1101-8.
PMID: 7047886
DOI: 10.1007/BF01746197.
Characterization of the cytotoxin produced by macrophages in response to dengue virus-induced cytotoxic factor.
Gulati L, Chaturvedi U, Mathur A
Br J Exp Pathol. 1983; 64(2):185-90.
PMID: 6849814
PMC: 2040686.
Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.
Laurence J, Gottlieb A, KUNKEL H
J Clin Invest. 1983; 72(6):2072-81.
PMID: 6605980
PMC: 437048.
DOI: 10.1172/JCI111172.
T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies.
Platsoucas C, Hansen H, Redman J, Berenson S, Lee 3rd B, Clarkson B
J Clin Immunol. 1983; 3(3):277-84.
PMID: 6604067
DOI: 10.1007/BF00915352.
Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor.
Ye Q, Mokyr M, Pyle J, Dray S
Cancer Immunol Immunother. 1984; 16(3):162-9.
PMID: 6561068
PMC: 11039285.
DOI: 10.1007/BF00205423.
The mode of action of splenic suppressor cells in murine plasmacytoma.
Chen Y, Heller P
Clin Exp Immunol. 1981; 45(3):514-22.
PMID: 6461449
PMC: 1537407.
Immunoregulatory T cell function in multiple myeloma.
Ozer H, Han T, HENDERSON E, Nussbaum A, Sheedy D
J Clin Invest. 1981; 67(3):779-89.
PMID: 6451635
PMC: 370629.
DOI: 10.1172/JCI110095.
Diffusible suppressor factor from splenic macrophages in murine plasmacytoma.
Chen Y, Heller P
Clin Exp Immunol. 1984; 57(1):171-7.
PMID: 6378461
PMC: 1536073.
Immunosuppression in plasmacytoma: induction of suppressor cells.
Chen Y, Hwang L, Heller P
Clin Exp Immunol. 1982; 47(1):191-6.
PMID: 6212173
PMC: 1536353.
Suppressor activity of splenic macrophages in murine plasmacytoma (PC) is inhibited by PC specific ligands.
Chen Y, Heller P
Clin Exp Immunol. 1982; 50(2):366-73.
PMID: 6185260
PMC: 1536697.
Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor.
Bocian R, Dray S, Ben-Efraim S, Mokyr M
Cancer Immunol Immunother. 1985; 20(1):61-8.
PMID: 3933817
PMC: 11038149.
DOI: 10.1007/BF00199775.
Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.
Bonaventure J, Nigam V, Brailovsky C
Cancer Immunol Immunother. 1985; 20(2):167-74.
PMID: 3849979
PMC: 11038706.
DOI: 10.1007/BF00205684.
Regulation of immunoglobulin synthesis by monocytes in multiple myeloma and benign monoclonal gammopathy.
Takeshita A
Clin Exp Immunol. 1986; 66(3):625-32.
PMID: 3568450
PMC: 1542457.
Modulation of the immune response to tumors by a novel synthetic compound, N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763).
Wang B, WALLACE R, CITARELLA R, Lin Y, DURR F
Cancer Immunol Immunother. 1986; 22(1):8-14.
PMID: 2939949
PMC: 11038504.
DOI: 10.1007/BF00205710.
Suppression of polyclonal B cell proliferation mediated by supernatants from human myeloma bone marrow cell cultures.
Peest D, Holscher R, Weber R, Leo R, Deicher H
Clin Exp Immunol. 1989; 75(2):252-7.
PMID: 2784737
PMC: 1542115.
